Ability of artificial intelligence to detect T1 esophageal squamous cell carcinoma from endoscopic videos and the effects of real-time assistance.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 04 2021
Historique:
received: 11 12 2020
accepted: 26 03 2021
entrez: 9 4 2021
pubmed: 10 4 2021
medline: 9 11 2021
Statut: epublish

Résumé

Diagnosis using artificial intelligence (AI) with deep learning could be useful in endoscopic examinations. We investigated the ability of AI to detect superficial esophageal squamous cell carcinoma (ESCC) from esophagogastroduodenoscopy (EGD) videos. We retrospectively collected 8428 EGD images of esophageal cancer to develop a convolutional neural network through deep learning. We evaluated the detection accuracy of the AI diagnosing system compared with that of 18 endoscopists. We used 144 EGD videos for the two validation sets. First, we used 64 EGD observation videos of ESCCs using both white light imaging (WLI) and narrow-band imaging (NBI). We then evaluated the system using 80 EGD videos from 40 patients (20 with superficial ESCC and 20 with non-ESCC). In the first set, the AI system correctly diagnosed 100% ESCCs. In the second set, it correctly detected 85% (17/20) ESCCs. Of these, 75% (15/20) and 55% (11/22) were detected by WLI and NBI, respectively, and the positive predictive value was 36.7%. The endoscopists correctly detected 45% (25-70%) ESCCs. With AI real-time assistance, the sensitivities of the endoscopists were significantly improved without AI assistance (p < 0.05). AI can detect superficial ESCCs from EGD videos with high sensitivity and the sensitivity of the endoscopist was improved with AI real-time support.

Identifiants

pubmed: 33833355
doi: 10.1038/s41598-021-87405-6
pii: 10.1038/s41598-021-87405-6
pmc: PMC8032773
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7759

Références

Endoscopy. 1999 May;31(4):281-5
pubmed: 10376452
Am J Gastroenterol. 2014 Jun;109(6):845-54
pubmed: 24751580
Hepatogastroenterology. 2009 Jan-Feb;56(89):63-6
pubmed: 19453030
Gastrointest Endosc. 2009 Mar;69(3 Pt 1):408-17
pubmed: 19019362
Gastrointest Endosc. 2020 Jan;91(1):41-51
pubmed: 31445040
N Engl J Med. 2003 Dec 4;349(23):2241-52
pubmed: 14657432
Gastrointest Endosc. 2001 Feb;53(2):199-202
pubmed: 11174292
Gastrointest Endosc. 2020 Oct;92(4):848-855
pubmed: 32505685
Dis Esophagus. 2010 Aug;23(6):480-6
pubmed: 20095991
Gastrointest Endosc. 2020 Feb;91(2):301-309.e1
pubmed: 31585124
Esophagus. 2017;14(1):1-36
pubmed: 28111535
Gastric Cancer. 2018 Jul;21(4):653-660
pubmed: 29335825
Esophagus. 2020 Jul;17(3):250-256
pubmed: 31980977
Cancer Discov. 2012 Oct;2(10):899-905
pubmed: 22877736
Esophagus. 2015;12:1-30
pubmed: 25620903
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Gastrointest Endosc. 2019 Jan;89(1):25-32
pubmed: 30120958
Dig Endosc. 2020 Nov;32(7):1057-1065
pubmed: 32064684

Auteurs

Sho Shiroma (S)

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Toshiyuki Yoshio (T)

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan. toshiyuki.yoshio@jfcr.or.jp.
Tada Tomohiro Institute of Gastroenterology and Proctology, Saitama, Japan. toshiyuki.yoshio@jfcr.or.jp.

Yusuke Kato (Y)

AI Medical Service Inc., Tokyo, Japan.

Yoshimasa Horie (Y)

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.

Ken Namikawa (K)

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Yoshitaka Tokai (Y)

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Shoichi Yoshimizu (S)

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Natsuko Yoshizawa (N)

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Department of Gastroenterology and Hepatology, Sagamihara Kyodo Hospital, Tokyo, Japan.

Yusuke Horiuchi (Y)

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Akiyoshi Ishiyama (A)

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Toshiaki Hirasawa (T)

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Tada Tomohiro Institute of Gastroenterology and Proctology, Saitama, Japan.

Tomohiro Tsuchida (T)

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Naoki Akazawa (N)

Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan.

Junichi Akiyama (J)

Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan.

Tomohiro Tada (T)

Tada Tomohiro Institute of Gastroenterology and Proctology, Saitama, Japan.
AI Medical Service Inc., Tokyo, Japan.
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Junko Fujisaki (J)

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH